Journal ArticleOPEN ACCESS

Lentinan Properties in Anticancer Therapy: A Review on the Last 12-Year Literature

  • Vannucci L
  • Sima P
  • Vetvicka V
  • et al.
American Journal of Immunology (2017) 13(1) 50-61
DOI: 10.3844/ajisp.2017.50.61
N/ACitations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

The effects of β-glucan in cancer are the most studied biological effects of β-glucan. From all available β-glucans, the most data are available on lentinan, mostly because it is used in clinical practice for over 20 years. Current review represent a state-of-the-art comprehensive review of knowledge obtained in last twelve years.

Cite

CITATION STYLE

APA

Vannucci, L., Sima, P., Vetvicka, V., & Krizan, J. (2017). Lentinan Properties in Anticancer Therapy: A Review on the Last 12-Year Literature. American Journal of Immunology, 13(1), 50–61. https://doi.org/10.3844/ajisp.2017.50.61

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free